A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy.
Deborah K McMahonLu ZhengJoshua C CyktorEvgenia AgaBernard J MacatangayCatherine GodfreyMichael ParaRonald T MitsuyasuJoseph HesselgesserJoan DragavonCurtis DobrowolskiJonathan KarnEdward P AcostaRajesh T GandhiJohn W MellorsPublished in: The Journal of infectious diseases (2022)
NCT01933594.